UBS sees Meta showing early signs of GenAI monetization through expanded Business Agent chatbot rollout

On June 4, UBS analyst Stephen Ju reiterated a Buy rating and $865.00 price target on Meta, citing clear signs that Meta is starting to monetize its GenAI-enabled Business Agent chatbot, which was formally expanded at the Conversations 2026 conference on June 3 to businesses of all sizes globally and to Instagram.

The chatbot was previously limited to beta testing and available only in some developing markets; the broader rollout suggests Meta's GenAI investments can turn into meaningful revenue streams over time.

UBS analysts noted that the product showcase supports their view that Meta remains on track to deliver the largest of its five new GenAI revenue streams and should alleviate investor concerns about its ability to deliver return on invested capital (ROIC) on its GenAI spending.